PROGNOSTIC TOOL TO HELP IDENTIFY PT1-3N0 PATIENTS LIKELY TO BENEFIT FROM ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY

被引:0
|
作者
Cha, Eugene
Chromecki, Thomas
Sun, Maxine
Svatek, Robert
Rink, Michael
Remzi, Mesut
Lotan, Yair
Novara, Giacomo
Seitz, Christian
Chun, Felix
Lee, Richard
Pummer, Karl
Pycha, Armin
Kassouf, Wassim
Ficarra, Vincenzo
Scherr, Douglas
Karakiewicz, Pierre
Shariat, Shahrokh
机构
来源
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词
D O I
10.1016/j.juro.2011.02.1309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1418
引用
收藏
页码:E568 / E568
页数:1
相关论文
共 50 条
  • [41] The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making
    Lee, Hayoung
    Yoo, Seung-Yeon
    Park, In Ja
    Hong, Seung-Mo
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    CANCERS, 2022, 14 (12)
  • [42] RADICAL CYSTECTOMY FOR HISTORICAL AND PATHOLOGIC-T1, N0, M0 (STAGE-A) TRANSITIONAL CELL-CANCER - NEED FOR ADJUVANT SYSTEMIC CHEMOTHERAPY
    SIREF, LE
    ZINCKE, H
    UROLOGY, 1988, 31 (04) : 309 - 311
  • [43] Patients with T4N0 and T1-3N1 colon cancer and a high preoperative carcinoembryonic antigen level benefit from adjuvant chemotherapy with oxaliplatin for 6 months
    Inoue, Hiroyuki
    Shimizu, Hiroki
    Kuriu, Yoshiaki
    Arita, Tomohiro
    Nanishi, Kenji
    Kiuchi, Jun
    Ohashi, Takuma
    Yamamoto, Yusuke
    Konishi, Hirotaka
    Morimura, Ryo
    Shiozaki, Atsushi
    Ikoma, Hisashi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [44] Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy
    Tabata, Mariko
    Ikeda, Masaomi
    Urakami, Shinji
    Takahashi, Shintaro
    Sakaguchi, Kazushige
    Kurosawa, Kazuhiro
    Okaneya, Toshikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 963 - 967
  • [46] FINAL PATHOLOGIC STAGE AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER: DOES PT0 PREDICT BETTER SURVIVAL THAN PTA/PTIS/PT1?
    Zargar, Homayoun
    Zargar-Shoshtari, Kamran
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    Van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E841 - E841
  • [47] COULD ADJUVANT CHEMOTHERAPY HAVE THERAPEUTIC BENEFIT AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EQUAL TO OR GREATER THAN PT3 MUSCLE INVASIVE BLADDER CANCER?
    Omura, Minami
    Kikuchi, Eiji
    Ogihara, Koichiro
    Hakozaki, Kyohei
    Fukumoto, Keishiro
    Kaneko, Go
    Miyazaki, Yasumasa
    Tanaka, Nobuyuki
    Shirotake, Suguru
    Kanai, Kunimitsu
    Matsumoto, Kazuhiro
    Nagata, Hirohiko
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2017, 197 (04): : E433 - E433
  • [48] No Survival Benefit From Postoperative Adjuvant Chemotherapy After D2 Radical Resection for the Patients With Stage II Gastric Cancer
    Chen, Shi
    Chen, Ying-Bo
    Zhou, Zhi-Wei
    Li, Wei
    Sun, Xiao-Wei
    Xu, Da-Zhi
    Li, Yuan-Fang
    Guan, Yuan-Xiang
    Feng, Xing-Yu
    Zhan, You-Qing
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 309 - 313
  • [49] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients
    Mark F. Berry
    Brooke K. Coleman
    Lesley H. Curtis
    Mathias Worni
    Thomas A. D’Amico
    Igor Akushevich
    Annals of Surgical Oncology, 2015, 22 : 642 - 648
  • [50] ADJUVANT PLATINUM-BASED CHEMOTHERAPY IMPROVED THE PROGNOSIS OF PATIENTS WITH PT3N0/XM0 UPPER URINARY TRACT CARCINOMA
    Kawashima, Atsunari
    Nakai, Yasutomo
    Nakayama, Masashi
    Ujike, Takeshi
    Tanigawa, Go
    Takeda, Ken
    Ono, Yutaka
    Yoshioka, Toshiaki
    Takada, Tsuyoshi
    Yamaguchi, Yuichiro
    Sato, Mototaka
    Hatano, Koji
    Mukai, Masatoshi
    Nagahara, Akira
    Oka, Daizo
    Takayama, Hitoshi
    Nishimura, Kazuo
    Nonomura, Norio
    JOURNAL OF UROLOGY, 2011, 185 (04): : E272 - E272